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Predicting outcomes after blunt chest wall trauma:
development and external validation of a new
prognostic model
Ceri Elisabeth Battle1,2,3*, Hayley Hutchings1, Simon Lovett1, Omar Bouamra4, Sally Jones5, Aruni Sen6, James Gagg7,
David Robinson8, Jake Hartford-Beynon9, Jeremy Williams10 and Adrian Evans1,3
Abstract
Introduction: Blunt chest wall trauma accounts for over 15% of all trauma admissions to Emergency Departments
worldwide. Reported mortality rates vary between 4 and 60%. Management of this patient group is challenging as
a result of the delayed on-set of complications. The aim of this study was to develop and validate a prognostic
model that can be used to assist in the management of blunt chest wall trauma.
Methods: There were two distinct phases to the overall study; the development and the validation phases. In the
first study phase, the prognostic model was developed through the retrospective analysis of all blunt chest wall
trauma patients (n = 274) presenting to the Emergency Department of a regional trauma centre in Wales (2009 to
2011). Multivariable logistic regression was used to develop the model and identify the significant predictors for the
development of complications. The model’s accuracy and predictive capabilities were assessed. In the second study
phase, external validation of the model was completed in a multi-centre prospective study (n = 237) in 2012. The
model’s accuracy and predictive capabilities were re-assessed for the validation sample. A risk score was developed
for use in the clinical setting.
Results: Significant predictors of the development of complications were age, number of rib fractures, chronic lung
disease, use of pre-injury anticoagulants and oxygen saturation levels. The final model demonstrated an excellent
c-index of 0.96 (95% confidence intervals: 0.93 to 0.98).
Conclusions: In our two phase study, we have developed and validated a prognostic model that can be used to
assist in the management of blunt chest wall trauma patients. The final risk score provides the clinician with the
probability of the development of complications for each individual patient.
Introduction
Blunt chest-wall trauma accounted for over 15% of all
trauma admissions to Emergency departments (EDs)
worldwide [1]. Reported mortality ranges between 4
and 60%, however, no current national guidelines exist
to assist in the management of this patient group unless
the patient has severe, immediate life-threatening injuries
[2]. The difficulties in the management of the blunt
chest-wall trauma patient are becoming increasingly well
recognised in the literature [3,4]. The blunt chest-wall
trauma patient commonly presents to the ED initially with
no respiratory difficulties, but can develop respiratory
complications approximately 48 to 72 hours later [5,6].
Clinical symptoms are not considered an accurate pre-
dictor of outcome following non-life threatening blunt
chest-wall trauma [7]. Decisions on the appropriate level
of care required by the patient following discharge from
the ED are therefore difficult, which is further compounded
by the lack of current national guidelines. A number of
well-documented risk factors for morbidity and mortality
exist for blunt chest-wall trauma, including patient age,
pre-existing disease, number of ribs fractured and the onset
of pneumonia during the recovery phase [2,8].
A prognostic model enables the clinician to use combi-
nations of predictor values to estimate a probability that a
specified outcome will occur [9]. The resulting model may
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be used to divide the patient into categories of risk or
predict probabilities of a pre-specified outcome [9]. A
number of models exist for blunt chest trauma, however,
most are designed for use with patients with multiple
injuries and very few have been externally validated or
presented in a clinically practical way [3]. For the purpose
of this study, blunt chest-wall trauma was defined as blunt
chest injury resulting in chest wall contusion or rib frac-
tures, with or without non-immediate life-threatening lung
injury [2]. We have developed and validated a prognostic
model for the development of complications following
blunt chest-wall trauma. Using the results of the prognos-
tic model, we have also developed a simple risk score for
use in the clinical setting which can assist the clinician in
the management of the blunt chest-wall trauma patient.
Materials and methods
There were two distinct phases to the overall study; the
development and the validation phases. Published guide-
lines for prognostic model development were followed
throughout the completion of this work [9-12]. These
guidelines outlined the stages of model development
and the appropriate statistical analysis that should be
undertaken at each phase [9-12].
Development phase study design
Data were collected retrospectively from the medical notes
of each patient. If there was no record in the patient’s notes
of chronic lung disease, cardiovascular disease, use of pre-
injury anticoagulants or current smoking status, then it was
assumed that these predictors were absent. The number of
rib fractures was determined from the chest radiograph if
not documented in the medical notes.
Patients
The prognostic model was developed on a sample of 276
patients who presented to the ED of a large regional
trauma centre in South Wales between 2009 and 2011,
with a primary diagnosis of blunt chest-wall trauma.
Patients were excluded if they were under 18 years of
age or if they had sustained any immediate life-threatening
injury. As eight prognostic variables were under investiga-
tion, a total of 80 blunt chest-wall trauma patients who
developed complications were needed in the analysis [13].
Outcomes
The development of complications following blunt chest-
wall trauma was the composite outcome measure investi-
gated in this study. Data collection for this outcome was
completed from the time the patient presented to the ED
through to discharge from hospital. Patients were reported
to have developed complications if one or more of the
following were documented in their medical records;
in-hospital mortality, morbidity including all pulmonary
complications (chest infection, pneumonia, haemothorax,
pneumothorax, pleural effusion, or empyema), ICU admis-
sion, or a prolonged length of stay as defined as a total
hospital stay of seven or more days [14,15].
Prognostic variables
For the development of the prognostic model, we consid-
ered age, number of rib fractures, chronic lung disease,
cardiovascular disease, use of pre-injury anti-coagulants,
smoking status and oxygen saturations and respiratory
rate on initial assessment in the ED. These risk factors
were based on previous research [2,8,16].
Analysis
Baseline characteristics were presented as median and
interquartile range (due to non-normal distributions) for
the continuous variables and numbers and percentages
for categorical variables. Differences between the base-
line characteristics in the development and validation
samples were analysed using the Mann-Whitney U-test
(continuous variables) and Fisher’s exact test (categorical
variable). Odds ratios and 95% CI were presented from
the univariable analysis. All significant prognostic variables
at 5% significance on the univariable analysis were included
in final analysis. Multivariable logistic regression analysis
using fractional polynomials (to assess linearity of the con-
tinuous variables) identified five significant predictors using
the Akaike information criterion with a backward elimin-
ation approach. We quantified the predictive contribution
of each variable by its z-score (the regression coefficient
divided by its standard error). There was less than 2% miss-
ing data, therefore we used a simple imputation method to
avoid exclusion of patients from the final analysis [17].
Performance of the model
The final prognostic model was based on five prognostic
variables which were significant at the P <0.05 level
following multivariable logistic regression analysis. We
assessed model performance using analysis of calibration
and discrimination. Calibration was assessed graphically
and with the Hosmer-Lemeshow test. Discrimination was
assessed with the c-statistic (equivalent to the area under
the receiver operator curve) [17].
Validation phase study design
A multi-centre prospective study design was used in
order to externally validate the model, in which seven
hospitals in England and Wales between 2012 and 2013
participated in data collection. A total of 237 patients
was included, which was a sufficient sample size for a
validation study [18]. The model was validated by compar-
ing predicted versus observed outcomes and performance
assessed using calibration and discrimination analysis. As
a result of the lower calibration in the validation model,
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the final model was updated through the application of
a correction factor to adjust the slope intercept of the
original model. This technique is outlined in the guide-
lines by Janssen et al. [19]. Sensitivity, specificity, positive
and negative predictive values were calculated for the
final model.
Score development
We developed a simple clinical score based on the regres-
sion coefficients from the final model. To calculate the
risk score for the individual predictors, the coefficient
of each predictor was multiplied by a factor so that the
smallest coefficient was transformed into a value close
to one. This method was adapted from previous studies
[20,21]. These individual scores were then added to-
gether to provide an overall risk score for each patient.
Using the validation sample, each patient’s final overall
risk score was compared to their probability of developing
complications initially calculated using the final logistic
regression equation. The individual final risk scores
were categorised into groups (0 to 10, 11 to 15, 16 to
20, 21 to 25, 26 to 30 and ≥30) and the mean and
standard deviation of all the corresponding probabilities
were calculated. This would provide the clinician with a
probability of the development of complications for
each possible final risk score. Estimates of appropriate
cut off points were included guiding the clinician as to
whether the patient could be safely discharged home,
or whether they should be admitted to a ward or intensive
care unit.
Ethical approval
Full ethical approval for this study was granted by the
South West Wales Research Ethics Committee. Written
consent to participate and publish study findings was
provided by each recruited patient.
Results
General characteristics
Table 1 illustrates the baseline characteristics of the
patients comparing the development and validation sam-
ples. Significant differences were recorded in rate of
outcome and most predictors between the two groups.
More of the patients were male (64%) and the most
common injury mechanisms were fall (72%), road traffic
accident (14%), sporting injury (9%) and assault (3%). A
total of 31 (6%) deaths was recorded in both samples.
Development phase univariable analysis
Results of the univariable analysis (in the development
sample only) highlighted a number of significant predictors
for the development of complications. Unadjusted odds
ratios and the 95% CI are included for each of the cat-
egorical variables.
Development phase multivariable analysis
All eight predictors from Table 2 were included in the
analysis (from the development sample only). Five sig-
nificant predictors were included in the final model: age,
number of rib fractures, chronic lung disease, use of pre-
injury anticoagulants and oxygen saturations (Table 3).
Continuous variables were analysed as linear terms as
there was no indication of non-linearity when analysed
using the multivariable fractional polynomials. The num-
ber of rib fractures and chronic lung disease were the
strongest predictors of the development of complications
following blunt chest-wall trauma.
Performance of model
The model showed excellent discrimination with a c-statis-
tic of 0.80 (95% CI 0.75, 0.85). The model calibration is
illustrated in the observed versus predicted outcomes graph
in Figure 1. The model showed good calibration when
evaluated with the Hosmer Lemeshow test (9.22, P = 0.32).
External validation
In the validation phase of the study, the model was
prospectively externally validated in seven hospitals in
England and Wales. Discrimination of the final validation
model was excellent with a c-index of 0.96 (95% CI 0.93,
0.98), although an increase in the c-statistic is unusual in a
validation study. As expected, calibration was poorer in
the validation model (Figure 2), therefore, we updated the
model. The slope intercept of the development model was
adjusted using a correction factor to correspond with the
lower complication rate in the validation sample, which
gave an improved discrimination and calibration (Figure 2).
The results demonstrated that final model sensitivity
was 80%, specificity was 96%, positive predictive value
was 93% and negative predictive value was 86%.
Clinical score
Based on the results of the logistic regression analysis, we
developed a simplified clinical score by transforming the
regression coefficient of each predictor into an equiva-
lent accurately weighted risk integer score (Table 4).
For example, a 67-year-old (score 6) patient with three
rib fractures (score 9), a history of chronic lung disease
(score 5) and oxygen saturations of 87% (score 4) would
have a final risk score of 24 points.
Table 5 illustrates the final risk scores and their cor-
responding probability of developing complications
following blunt chest-wall trauma. Using these results,
for example, it is possible to estimate that a patient
who scores 12 has a 29% (±8) probability of developing
complications compared to a patient with a final risk score
of 36 who has an 88% (±7) probability of developing
complications.
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A final total risk score of ≥11 was the most accurate cut
off point (in terms of sensitivity, specificity and predictive
values) at which the blunt chest-wall trauma patient was
considered at risk of developing complications. The
percentage of patients who would have been correctly
managed (admitted to hospital and subsequently developed
complications) was 90% and those correctly discharged dir-
ectly from the ED (who had not developed complications)
would have been 87%. If a final risk score ≥26 was selected
as the cut off point at which the blunt chest-wall trauma
patient was considered a high enough risk to require
ICU admission, then the percentage of patients correctly
managed (scored at ≥26 and the observed outcome was
ICU admission) was 95%. The percentage of patients who
would have been incorrectly managed (scored at ≥26 but
were not admitted to the ICU in the observed outcome)
would have been 11%.
Discussion
We have developed and validated a prognostic model for
predicting the development of complications following
blunt chest-wall trauma. The final model has excellent
discrimination suggesting that the clinician can confidently
assess whether the patient with the higher risk prediction
using the model will develop complications following blunt
chest-wall trauma, compared to the patients with low
risk predictions who will not develop complications. As
expected, the validation model demonstrated poorer cali-
bration and numerous authors have offered explanations
for this result in a validation sample [22,23]. It is likely
that the poor calibration was due to the significantly
lower rates of the development of complications in the
validation sample.
Common practice is simply to reject an original predic-
tion model as a result of decreased predictive performance
in the validation sample. A new prediction model is then
developed and as a consequence the original dataset is
neglected and clinicians are faced with numerous possible
prediction models, very few of which have been externally
validated for use in new samples [22]. Research now
suggests that the model should be adjusted in order to
improve its performance on the new population and
this adjusted model is then based on both the original
and validation data, further strengthening its stability
and generalisability [9]. The model in this validation
study was therefore updated using a previously described
Table 1 Comparison between baseline characteristics of patients in the development and validation samples
Development
sample total
No
complications
Complications Validation
sample total
No
complications
Complications P-value
274 113 (41%) 161 (59%) 237 161 (57%) 103 (43%) <0001*
Age 69 (28) 62 (30) 76 (21) 57 (34) 47 (31) 71 (29) <0001*
Number of rib fractures 3 (3) 2 (3) 3 (1) 1 (3) 0 (1) 3 (3) <0.001*
Oxygen saturations 95 (5) 96 (4) 94 (6) 97 (5) 98 (2) 95 (7) <0.001*
Respiratory rate 18 (6) 18 (4.5) 20 (6.5) 18 (6) 16 (2) 20 (6) 0.062
Chronic lung disease 154 (56%) 38 (34%) 116 (72%) 49 (21%) 13 (8%) 36 (35%) <0.001*
Cardiovascular disease 116 (42%) 34 (30%) 82 (51%) 53 (22%) 13 (8%) 40 (39%) <0.001*
Smoker 92 (34%) 43 (38%) 49 (30%) 67 (28%) 40 (25%) 27 (26%) 0.213
Pre-injury
anticoagulants
117 (43%) 28 (25%) 89 (55%) 47 (20%) 6 (4%) 41 (40%) <0.001*
Number (percentages), median (interquartile range). *Significant difference (P-value) between totals in development and validation samples.
Table 2 Univariable analysis: unadjusted odds ratios for the predictors of the development of complications
No complications n = 113 Complications n = 161 P-value Unadjusted odds
ratios (95% CI)
Age 47 31 71 (30.0) 0.0001*
Number of rib fractures 0 (1.0) 3 (1.0) 0.0001*
Oxygen saturations 98 (2.0) 95 (7.0) 0.0001*
Respiratory rate 18 (6.0) 20 (8.0) 0.0794
Chronic lung disease 38 (34%) 116 (72%) 0.0001* 5.1 (3.0, 8.6)
Pre-injury anticoagulants 28 (25%) 89 (55%) 0.0001* 3.8 (2.2, 6.4)
Cardiovascular disease 34 (30%) 82 (51%) 0.0008* 2.4 (1.5, 4.0)
Smoking status 43 (38%) 49 (30%) 0.1964 0.7 (0.4, 1.2)
Number and percentages, median (interquartile). *Significant difference (P-value).
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method known as recalibration [19,23]. By simply adjust-
ing the intercept for the original model, the validation
model calibration was improved.
Patient age, number of rib fractures, chronic lung disease,
pre-injury anticoagulants and oxygen saturation levels were
the significant risk factors for development of complications
following blunt chest-wall trauma. Patient age, number of
rib fractures and chronic lung disease have been reported
as significant risk factors for poor outcomes in a number of
recent studies and possible explanations for these factors
have been previously discussed [2,16,24]. Pre-injury anti-
coagulant use and oxygen saturation levels have only been
reported as risk factors for the development for complica-
tions following blunt chest-wall trauma in a previous study
by Battle et al. [2] and therefore, further research into these
risk factors would be beneficial [16].
The results of this study have demonstrated that risk
can be easily and accurately stratified from simple demo-
graphic and clinical variables on initial assessment of the
blunt chest-wall trauma patient in the ED. The risk factors
are all currently routinely measured in the ED and do not
require expensive, time-consuming or complicated tech-
nology to investigate. This is one of the most important
factors in the success of prognostic model development
according to previous research [9]. The clinician would
simply collect routine data, total the scores for each risk
factor, then obtain the corresponding probability of the
development of complications. A more accurate decision
can be made by the clinician on whether the patient is safe
for discharge home directly from the ED, or whether the
patient requires admission to hospital. Not only could this
reduce the development of complications in blunt chest-
wall trauma patients through close observation and early
aggressive prophylactic treatment in the admitted patient,
but also reduce unnecessary admission of patients unlikely
to develop complications.
The overall results of this study suggest that the final
validation model could be safely and effectively used in
the clinical setting in England and Wales for assisting in
the management of blunt chest-wall trauma patients. This
is the first prognostic model that has been developed and
externally validated in a prospective multi-centre study for
use with blunt chest-wall trauma patients. The model can
be used with the less severely injured patient who on
presentation to the ED is not suffering any overt signs of
respiratory distress, but will potentially go on to develop
severe life-threatening pulmonary complications. Research
has demonstrated that careful observation and early
aggressive therapy can limit these complications, there-
fore identification of the high-risk patient is imperative
for optimal management [25]. It is inevitable, however,
that the final decision on patient management must be
individualised and many factors that cannot be translated
into a statistical model must be considered. The overall
purpose of the prognostic model is simply to guide clinical
decision-making, not replace it.
This study has a number of strengths and limitations.
External validation using a prospective multi-centre trial
is considered the most robust validation technique en-
suring generalisability of the study’s results [9]. Current
methodological recommendations for clinical prediction
research, as outlined by Bouwmeester et al. [17] have been
followed in the design and completion of the prognostic
model for use with blunt chest-wall trauma patients.
These recommendations included sample size and selec-
tion, clear definitions of risk factors and outcomes under
investigation, handling of missing data, reporting of both
univariable and multivariable results and calculation of
model performance measures. The final model was also
recalibrated as recommended by recent research [19]. As
a result the reliability and applicability is sufficient that the
model could be safely and effectively used in the clinical
setting. The external validation results also confirm the
Table 3 Multivariable predictive model
Predictor Odds ratio (95% CI) z-score
Agea 1.0 (1.0, 1.0) 1.80
Number of rib fracturesb 1.5 (1.3, 1.9) 4.21
Chronic lung disease 2.2 (1.2, 4.1) 2.50
Pre-injury anticoagulants 1.9 (1.0, 3.7) 1.91
Oxygen saturationsc 0.9 (0.9, 1.0) −1.55
aPer one year increase; bper one fracture increase; cper 1% decrease of
oxygen saturations.
Figure 1 Calibration of model using expected and observed
probabilities of development of complications. Triangles show risk
of outcome in tenths of patients with similar predicted probabilities.
Dotted line: relationship between observed frequency and predicted
probability of development of complications; broken line: ideal
relationship between observed and predicted frequency of
outcome in model with perfect calibration.
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clinical usefulness of the model in blunt chest-wall
trauma management throughout England and Wales. It
is important to emphasise, however, that the validation
model c-statistic is a very unusual result and should be
interpreted with caution. It is more common for the c-
statistic to decrease in the validation study, rather than
to increase as we found.
One of the limitations of this study is the loss of patients
to follow up. Due to limited resources, it was not consid-
ered feasible to investigate the patients’ follow up once
they had left hospital care. Any use of primary care for
complications that developed following hospital discharge
would not have been included in the study results. The
data collection was not fully blinded as recommended by
Bouwmeester et al. [17], however, the clinicians collecting
the data in the validation study were blinded to which of
the risk factors and outcomes were being used in the final
analysis. Another limitation of the validation study con-
cerns the timing of the data collection. For example, the
patient’s oxygen saturation levels may have varied accord-
ing to the time in which they were recorded. If the data
were collected before analgesia was given in the ED, then
the results may have been worse than if the patient had
received analgesia and could breathe more easily. As a
result of these limitations, the results of this study
should be considered with caution.
There was a significantly lower rate of complications
in the validation sample than the development sample.
This could be explained by the protocol for management
of the blunt chest-trauma patient in the different hospitals.
Figure 2 External validation model calibration using observed versus predicted outcomes. Red diamonds show risk of outcome in tenths
of patients with similar predicted probabilities with intercept value of 3.72. Green triangles show risk of outcome in tenths of patients with similar
predicted probabilities with updated intercept value of 3.97. Black broken line: ideal relationship between observed and predicted frequency of
outcome in model with perfect calibration; red broken line: relationship between observed frequency and predicted probability of development
of complications in original validation model; green line: relationship between observed frequency and predicted probability of development of
complications in updated validation model.
Table 4 Risk factor scores as transformed from the
regression coefficients
Regression coefficient Risk score
Age 0.0162 1a
Number of rib fractures 0.418 3b
Chronic lung disease 0.789 5
Pre-injury anticoagulant use 0.637 4
Oxygen saturation levels −0.0651 2c
aPer additional 10-year increase starting at 10 years of age; bper additional rib
fracture; cper 5% decrease in oxygen saturations starting at 94%.
Table 5 Final risk scores and corresponding probability of
developing complications
Final risk score Probability mean ± SD
0 to 10 13% ± 6
11 to 15 29% ± 8
16 to 20 52% ± 8
21 to 25 70% ± 6
26 to 30 80% ± 6
31+ 88% ± 7
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For example, in the hospital where the original model was
developed, patients are routinely admitted to the ICU if
they need invasive analgesia such as an epidural, as this is
where epidural patients are currently managed. In order
to quantify the number of rib fractures sustained by the
patient, a chest radiograph or computed tomography (CT)
scan and its subjective interpretation is required. Due to
the inherent difficulties in identification of rib fractures
on chest radiographs, the clinician is advised to record
the number of rib fractures identified on imaging, or
suspected clinically following physical examination of
the patient [26].
The use of a composite outcome measure could result
in one element dominating the total outcome measure.
This was not the case in this study, however, as apart
from the low mortality rate, there was a relatively even
number of the different types of reported complications.
Conclusions
Blunt chest-wall trauma patients are often difficult to
manage in the ED, due to the frequent onset of delayed
complications. We have developed and validated a prognos-
tic model, which can assist the clinician in the management
of the blunt chest-wall trauma patient. The model has
demonstrated excellent prediction capabilities and can
be safely used in EDs managing this patient group.
Key messages
 Blunt chest-wall trauma patients can be difficult to
manage in the ED due to the frequent onset of
delayed complications
 Risk factors for the development of complications
following blunt chest-wall trauma were patient age,
number of rib fractures, chronic lung disease, use of
pre-injury anticoagulants and oxygen saturations
 The prognostic model developed and externally
validated in this study can be safely used to assist in
the management of the blunt chest-wall trauma
patient in the ED
 The prognostic model demonstrates excellent
predictive capabilities
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